Peritoneal Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Ten new medicines recommended for approval by EMA - The Pharmaceutical Journal



Ten new medicines recommended for approval by EMA 
The Pharmaceutical Journal
Bevacizumab (Mvasi; Amgen), for the treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix, was the only ...

 


Nita Ahuja Named Chair of Surgery - Yale News



Yale News
 
Nita Ahuja Named Chair of Surgery 
Yale News
She directs the multidisciplinary programs in soft tissue sarcoma and gastric cancers. She has developed an international reputation for management of peritoneal cancer metastases with cytoreduction and heated intraperitoneal chemotherapy, which ...

 


Slow, Innovative Abdominal Surgery Fights Cancer - Atlanta Jewish Times



Atlanta Jewish Times
 
Slow, Innovative Abdominal Surgery Fights Cancer 
Atlanta Jewish Times
?My interest lies in the peritoneal surface malignancies,? Winer said, ?and that's dealing with cancers that have spread to the abdominal cavity beyond the organ where they started. We do somewhere around 100 cases a year here at Emory.? Winer said the ...

 


Discover the Growth of the Peritoneal Cancer Market - LANews By Abhishek Budholiya (press release) (blog)



Discover the Growth of the Peritoneal Cancer Market 
LANews By Abhishek Budholiya (press release) (blog)
Peritoneal cancer is a rare cancer that develops in peritoneum, a thin, dedicate sheet that lines the inside wall of the abdomen and covers the uterus and extends over the bladder and rectum. The peritoneum is made up of epithelial cells. The ...

and more » 


Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with ... - Dove Medical Press



Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with ... 
Dove Medical Press
Background: Goblet cell carcinomas (GCCs) of the appendix are rare and aggressive malignancies with early peritoneal dissemination. The aim of the present article is to describe our experience in the management of GCCs with peritoneal carcinomatosis ...

 


Despite phase 2 miss, Daiichi Sankyo wants Glycotope lead antibody for cancer ADC - FierceBiotech



FierceBiotech
 
Despite phase 2 miss, Daiichi Sankyo wants Glycotope lead antibody for cancer ADC 
FierceBiotech
The German biotech is putting its lead PankoMab-GEX candidate gatipotuzumab, which targets the tumor-associated MUC1 antigen and has reached the phase 2b testing stage in ovarian or fallopian tube and peritoneal cancer, into the alliance. Daiichi ...

and more » 


Tesaro Takes A Swipe At AstraZeneca's Ovarian Cancer Drug Sales - Investor's Business Daily



Investor's Business Daily
 
Tesaro Takes A Swipe At AstraZeneca's Ovarian Cancer Drug Sales 
Investor's Business Daily
"More than 90% of Zejula use is in patients with ovarian, fallopian and primary peritoneal cancer." AstraZeneca's press release doesn't detail whether inventory buildup is included in its Lynparza sales figure for the quarter. AstraZeneca ...
SEC FORM 4 - SEC.gov SEC.gov

all 102 news articles » 


Approval Sought for Avastin in the Frontline Ovarian Cancer Setting - Curetoday.com



Curetoday.com
 
Approval Sought for Avastin in the Frontline Ovarian Cancer Setting 
Curetoday.com
If approved, the new indication would make frontline Avastin available in combination with carboplatin and paclitaxel, followed by Avastin alone, for women with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. The FDA is ...

 


New Options Are Being Explored in Ovarian Cancer - Cure Today - Curetoday.com



Curetoday.com
 
New Options Are Being Explored in Ovarian Cancer - Cure Today 
Curetoday.com
A NOVEL ANTIBODY-DRUG conjugate is being investigated as a single-agent treatment for patients with advanced, platinum-resistant epithelial ovarian cancer ...

and more » 


FDA Accepts sBLA for Bevacizumab in First-Line Ovarian Cancer - OncLive



OncLive
 
FDA Accepts sBLA for Bevacizumab in First-Line Ovarian Cancer 
OncLive
The FDA has accepted a supplemental biologics license application (sBLA) for bevacizumab (Avastin) for the first-line treatment of advanced ovarian cancer, ...

and more »